Article
[Clinical value of the CA 19-9 tumor marker with special reference to the Lewis phenotype].
Medizinische Klinik (Munich, Germany : 1983) - 15 Apr 1997
Kolb G, Safi F, Beckh K, Beger H G
Abstract excerpt
BACKGROUND: Because of structure and biosynthesis of CA 19-9, it was postulated that patients with the Lewis phenotype Le(a-b-) are not able to synthesize CA 19-9. But some patients with Le(a-b-) on red blood cells showed elevated levels of this tumor marker. PATIENTS AND METHOD: In 164 patients suffering from benign or malignant diseases both CA 19-9 and the Lewis phenotype were determined in sera. In addition...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.